Dena Grayson, MD, PhD, SVP Clinical Development & Medical Affairs at Kyverna Therapeutics on Media Training, Communication within Biotech, and Dealing with Fake CVs

Dena Grayson, MD, PhD, SVP Clinical Development & Medical Affairs at Kyverna Therapeutics on Media Training, Communication within Biotech, and Dealing with Fake CVs

In this episode, I talked with Dr. Dena Grayson, a physician–scientist with over two decades in biotech drug development. At the time of this recording, she was SVP and Head of Clinical Development at Keros Therapeutics, leading programs in rare bone marrow disorders, and she has since become SVP of Clinical Development and Medical Affairs at Kyverna Therapeutics. Earlier in her career, she helped advance Repatha at Amgen, and her path has also included running for Congress and serving as a national media voice during COVID.

Dena shares what it was like being the only MD–PhD in Amgen’s business development group, how she transitioned into clinical development, and the lessons she carried forward from her time in both politics and national media, where she became a trusted voice during the COVID pandemic. We dive into the real difference between presenting “the what” and explaining “the so what,” and why communication often makes or breaks careers in biotech.

Alongside her professional journey, Dena opens up about the wildest recruitment experience she’s ever had, her approach to building strong teams, and why patience in hiring beats rushing a decision. And in our quick-fire round, she shares stories from her days as a state champion soccer player, her love of surfing, and how she unwinds outside biotech.

(Find out more in the episode.)

Here’s What You’re In For

  1. How a political campaign loss led to a media career during COVID
  2. How to handle interviews when you’re introverted
  3. The kinds of questions that truly impress hiring managers


Timestamps

01:10 – Landing her first industry role at Amgen

03:24 – Repatha and investigational therapies at Keros

04:49 – Surfing, soccer, and state championships

07:08 – From political spouse to running for Congress

08:42 – Becoming a media commentator during COVID

10:41 – Communication lessons: from “what” to “so what”

15:14 – Advice for introverts in interviews and early career roles

17:37 – How thoughtful questions can change the dynamic in an interview

21:02 – Nearly 20 years as a hiring manager: what’s changed and what hasn’t

23:11 – Advice for junior hiring managers and why patience matters

25:37 – A candidate with a completely fabricated CV—the wildest recruitment story


About Dena

Dr. Dena Grayson is a physician–scientist (MD, PhD) with over 20 years in biotech drug development. At the time of this recording, she was SVP and Head of Clinical Development at Keros Therapeutics, leading programs in rare bone marrow disorders, and she has since become SVP of Clinical Development and Medical Affairs at Kyverna Therapeutics. Earlier in her career, she helped advance Repatha at Amgen, and her path has also included running for Congress and serving as a national media voice during COVID, experiences that shaped her belief that communication is as critical as science in driving biotech forward.

Connect with Dena:

  1. LinkedIn: https://www.linkedin.com/in/denaminninggrayson/
  2. Website: https://kyvernatx.com/


About me

My name is Charles Spence and I lead Discera. After many years working in the life-science recruitment world, I decided to work for myself. Before doing recruitment I graduated with a biomedical degree, have worked in hospitals (including translation work in Seoul, South Korea), and also spent a year working in diabetes research in Stockholm. After doing research and travel, a career in business and science felt the most appropriate.

In 2023, I decided to launch my firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.

Connect with me:

  1. LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/
  2. Website: https://www.discera-search.com/



Opinions and comments expressed by the guest do not represent the company and are fully their own.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(71)

Tobias Kampfenkel, MD, MHBA, Vice President of Early Clinical Development and Translational Research at Miltenyi Biomedicine, on Transformative Drugs in Oncology and Autoimmunity: It's Always the Team!

Tobias Kampfenkel, MD, MHBA, Vice President of Early Clinical Development and Translational Research at Miltenyi Biomedicine, on Transformative Drugs in Oncology and Autoimmunity: It's Always the Team!

In this episode, I talked with Dr. Tobias Kampfenkel, Vice President of Early Clinical Development and Translational Research at Miltenyi Biomedicine. Tobias spent nearly a decade at Janssen building ...

15 Kesä 39min

Sofia Heigis, CEO of OncoPeptides, From Sales Rep to CEO, Being "Present", and Hiring for Self-Insight

Sofia Heigis, CEO of OncoPeptides, From Sales Rep to CEO, Being "Present", and Hiring for Self-Insight

In this episode, I talked with Sofia Heigis, Chief Executive Officer of OncoPeptides, about a career path that did not start where she expected. Sofia originally wanted to move into clinical operation...

31 Touko 38min

Jens Lindberg, CEO at Medivir, on The Biotech Rollercoaster - Medivir´s Previous Four Months (and Biotech Today in 2026)

Jens Lindberg, CEO at Medivir, on The Biotech Rollercoaster - Medivir´s Previous Four Months (and Biotech Today in 2026)

In this episode, I talked with Jens Lindberg, CEO of Medivir AB, a Swedish biotech developing innovative therapies in liver cancer and rare disease. Jens brings over 30 years of late-stage development...

18 Touko 33min

Hubert Truebel,  Managing Director at DEBRA Research, on Creating Own Career Opportunities...and a Practical Approach to Longevity

Hubert Truebel, Managing Director at DEBRA Research, on Creating Own Career Opportunities...and a Practical Approach to Longevity

In this episode, I talked with Hubert Truebel, Managing Director at DEBRA Research, to discover a career that wasn’t built traditionally—but through creating opportunities where none formally existed....

4 Touko 28min

Sampreet Ramachandra, Head of Hematology Business Unit at Novartis Germany, on Launching Without a Playbook, Hiring Mistakes, and Leading with Equity

Sampreet Ramachandra, Head of Hematology Business Unit at Novartis Germany, on Launching Without a Playbook, Hiring Mistakes, and Leading with Equity

In this episode, I talked with Sampreet Ramachandra, Head of the Hematology Business Unit at Novartis Germany, about what it really takes to lead high-stakes launches — and what leadership looks like ...

30 Maalis 42min

Volker Wacheck, SVP at Taiho Oncology in Speaking Up, Asking vs. Accusing and Why Culture is So Important

Volker Wacheck, SVP at Taiho Oncology in Speaking Up, Asking vs. Accusing and Why Culture is So Important

In this episode, I talked with Volker Wacheck, SVP & Head of Clinical Development at Taiho Oncology, where he shared how a PI role in Vienna led him into industry, and why the hardest part wasn’t leav...

9 Maalis 29min

Richard Nkulikiyinka, Chief Medical Officer at Antag Therapeutics, on Career Pivots, Trust and Why Leadership Is Never Linear

Richard Nkulikiyinka, Chief Medical Officer at Antag Therapeutics, on Career Pivots, Trust and Why Leadership Is Never Linear

In this episode, I talked with Richard Nkulikiyinka, Chief Medical Officer at Antag Therapeutics, a Copenhagen-based biotech developing GIPR antagonists in the obesity space.Richard’s career began in ...

26 Tammi 35min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
psykopodiaa-podcast
rss-oivalluksia-rahasta-elamasta
mimmit-sijoittaa
rss-rahapodi
rahapuhetta
rss-karon-grilli
ostan-asuntoja-podcast
asuntoasiaa-paivakirjat
inderespodi
oppimisen-psykologia
rss-inderes
herrasmieshakkerit
rss-sami-miettinen-neuvottelija
hyva-paha-johtaminen
rss-rahamania
rss-porssipuhetta
rss-bisnesta-bebeja
rss-myynti-ei-ole-kirosana
rss-talouden-jaljilla